Mechanism of action
Diazepam is a positive allosteric modulator of the GABA-A receptor. It binds to a specific benzodiazepine binding site located at the interface between the alpha and gamma subunits of the GABA-A receptor complex. This binding increases the frequency of chloride channel opening in response to GABA, enhancing inhibitory neurotransmission throughout the central nervous system.
The result is CNS depression manifesting as anxiolysis, sedation, muscle relaxation, anticonvulsant effects, and anterograde amnesia. Unlike barbiturates, benzodiazepines do not directly open chloride channels but require GABA to be present, which provides a ceiling effect and relatively greater safety margin in overdose when taken alone.
Diazepam has a high lipid solubility, leading to rapid brain penetration and quick onset of action after oral or intravenous administration. This lipophilicity also causes redistribution from the CNS to peripheral tissues, which terminates the initial clinical effect but contributes to the prolonged elimination phase.
- Diazepam has active metabolites (desmethyldiazepam) with half-lives up to 100 hours, causing prolonged effects and accumulation in the elderly.
- Positive allosteric modulator of GABA-A receptor; increases frequency of chloride channel opening (barbiturates increase duration).
- Black box warning: concomitant use with opioids increases risk of respiratory depression, coma, and death.
- First-line for alcohol withdrawal due to long half-life; prevents seizures and delirium tremens.
- Flumazenil reverses benzodiazepine effects but can precipitate withdrawal seizures in dependent patients.
- Pregnancy Category D; risk of cleft palate, floppy infant syndrome, and neonatal withdrawal.
- Metabolized by CYP2C19 and CYP3A4; inhibitors like fluoxetine and cimetidine increase levels and toxicity risk.
- In cirrhosis, lorazepam and oxazepam are preferred because they undergo glucuronidation; diazepam undergoes oxidative metabolism and has significantly prolonged half-life in liver disease, increasing accumulation risk and encephalopathy risk.
Indications
Diazepam is indicated for multiple conditions across emergency, inpatient, and outpatient settings:
Acute anxiety disorders: Short-term relief of severe anxiety symptoms, though not recommended for chronic use due to tolerance and dependence risk.
Status epilepticus: First-line or adjunctive therapy for terminating prolonged seizures. Rectal diazepam gel is used in the prehospital setting and for pediatric rescue therapy.
Alcohol withdrawal syndrome: Reduces sympathetic hyperactivity, prevents seizures, and manages delirium tremens. Long half-life allows for symptom-triggered or fixed-schedule tapering protocols.
Muscle spasms: Provides relief in conditions such as cerebral palsy, paraplegia, athetosis, and stiff-person syndrome. The central muscle relaxant effect is mediated through spinal and supraspinal pathways.
Preoperative sedation: Used for anxiolysis and amnesia before procedures.
Tetanus: Adjunct therapy to reduce muscle rigidity and spasms.
Acute agitation: In emergency settings, diazepam may be used for rapid tranquilization, though antipsychotics are often preferred for primary psychiatric emergencies.
Pharmacokinetics
Diazepam exhibits complex pharmacokinetics that are clinically important, especially in vulnerable populations.
Absorption: Rapidly absorbed after oral administration with peak plasma concentrations in 30 to 90 minutes. Intramuscular absorption is slower and erratic, making this route less reliable. Rectal administration is used when IV access is unavailable.
Distribution: Highly lipophilic with a large volume of distribution. Diazepam is approximately 98% protein-bound, primarily to albumin. It readily crosses the blood-brain barrier and the placenta, and is found in breast milk.
Metabolism: Hepatic metabolism via CYP2C19 and CYP3A4 produces active metabolites, most notably desmethyldiazepam (nordiazepam), which has a half-life of 50 to 100 hours. Desmethyldiazepam is further metabolized to oxazepam and temazepam, both of which are also pharmacologically active. This cascade of active metabolites prolongs the clinical effect.
Elimination: The elimination half-life of diazepam itself is 20 to 50 hours, but when accounting for active metabolites, the effective duration of action can extend to several days. Renal excretion of conjugated metabolites follows hepatic metabolism. Half-life is prolonged in the elderly, neonates, and patients with hepatic impairment.
Special populations: In cirrhosis, clearance is significantly reduced and half-life may exceed 100 hours. Elderly patients experience increased CNS sensitivity and prolonged elimination, raising the risk of falls and cognitive impairment.
Adverse effects
Benzodiazepines share a common adverse effect profile, with diazepam's long duration amplifying certain risks.
Central nervous system
- Sedation and drowsiness: Most common, dose-related
- Cognitive impairment: Anterograde amnesia, confusion, impaired attention
- Ataxia and falls: Particularly dangerous in the elderly
- Paradoxical reactions: Agitation, aggression, disinhibition (more common in children and elderly)
- Respiratory depression: Especially when combined with opioids or alcohol; can be life-threatening
Tolerance and dependence
Chronic use leads to physiological dependence. Abrupt discontinuation after prolonged use triggers withdrawal symptoms including rebound anxiety, insomnia, tremor, seizures, and in severe cases, delirium. Tapering over weeks to months is required.
Other effects
- Hypotension: Particularly with rapid IV administration
- Injection site reactions: Phlebitis, thrombosis with IV use
- Gastrointestinal: Nausea, constipation
- Hepatotoxicity: Rare, typically with chronic use
- Anterograde amnesia: Patients may not recall events after administration
Overdose
Diazepam alone rarely causes fatal overdose, but combined with other CNS depressants (especially opioids or alcohol), it significantly increases the risk of respiratory arrest. Flumazenil is a competitive antagonist used in overdose, but it must be used cautiously as it can precipitate acute withdrawal and seizures in dependent patients.
Contraindications and warnings
Absolute contraindications:
- Hypersensitivity to benzodiazepines
- Acute narrow-angle glaucoma
- Severe respiratory insufficiency or sleep apnea (relative contraindication; risk-benefit must be assessed)
- Myasthenia gravis (can worsen muscle weakness)
Pregnancy and lactation: Diazepam is Pregnancy Category D. First-trimester use has been associated with cleft lip and palate in some studies, though causality remains debated. Use near delivery can cause floppy infant syndrome (hypotonia, hypothermia, respiratory depression). Chronic use during pregnancy can lead to neonatal dependence and withdrawal. Diazepam enters breast milk and can cause sedation and poor feeding in infants; breastfeeding is generally not recommended during treatment.
Hepatic impairment: Metabolism is significantly impaired in liver disease. Oxazepam or lorazepam, which undergo glucuronidation rather than oxidative metabolism, are preferred in cirrhosis.
Renal impairment: Dose adjustment is generally not required, but metabolites may accumulate with repeated dosing.
Elderly patients: Start with lower doses due to increased CNS sensitivity, prolonged half-life, and fall risk. Beers Criteria list benzodiazepines as potentially inappropriate in older adults.
Substance use disorders: High abuse potential; use with caution in patients with history of drug or alcohol abuse.
Respiratory disease: Use with caution in COPD, sleep apnea, or any condition compromising respiratory reserve.
Boxed warning: The FDA mandates a black box warning regarding the serious risks of concomitant use with opioids, which can result in profound sedation, respiratory depression, coma, and death.
Drug interactions
Diazepam is subject to numerous clinically significant drug interactions, primarily through pharmacodynamic synergy and CYP-mediated pharmacokinetic alterations.
CNS depressants
Opioids, alcohol, barbiturates, antipsychotics, sedating antihistamines: Additive CNS and respiratory depression. The combination with opioids carries a black box warning due to overdose risk.
CYP450 interactions
CYP2C19 and CYP3A4 inhibitors (e.g., fluoxetine, fluvoxamine, ketoconazole, erythromycin, cimetidine, omeprazole): Increase diazepam levels and prolong half-life, raising the risk of excessive sedation.
CYP inducers (e.g., rifampin, carbamazepine, phenytoin, St. John's wort): Decrease diazepam levels, potentially reducing efficacy.
Other interactions
- Antacids: May delay absorption but do not significantly affect total bioavailability
- Valproate: Inhibits metabolism, increasing diazepam levels
- Levodopa: Diazepam may reduce the efficacy of levodopa in Parkinson disease
- Theophylline: May antagonize the sedative effects of benzodiazepines
- Digoxin: Diazepam may increase digoxin levels (monitor)
Flumazenil
Competitive benzodiazepine antagonist used for reversal of sedation or overdose. Can precipitate acute withdrawal and seizures in chronic benzodiazepine users.
Clinical pearls
- Long half-life is a double-edged sword: The prolonged duration of action due to active metabolites makes diazepam ideal for alcohol withdrawal (smooth taper, less frequent dosing) but problematic in the elderly (accumulation, prolonged sedation).
- Rectal diazepam for seizures: Rectal gel formulation is used for out-of-hospital management of repetitive seizures, particularly in children with epilepsy. Caregivers can be trained to administer it.
- IV administration precautions: Give slowly (no faster than 5 mg/min in adults) to avoid hypotension, apnea, and phlebitis. Do not dilute or mix with other drugs in the same syringe or IV line, as diazepam can precipitate.
- Lorazepam is preferred for status epilepticus in many protocols: Though diazepam works faster initially due to higher lipophilicity, lorazepam has a longer duration of anticonvulsant action in the brain and is less prone to redistribution.
- Not first-line for chronic anxiety: Due to tolerance, dependence, and cognitive side effects, SSRIs or SNRIs are preferred for generalized anxiety disorder. Diazepam is reserved for short-term or breakthrough use.
- Tapering is mandatory: Abrupt cessation after more than a few weeks of regular use can cause life-threatening withdrawal seizures. Taper slowly, often over months for long-term users.
- Beware polypharmacy in the elderly: Benzodiazepines are a leading cause of falls, fractures, and cognitive decline in older adults. The Beers Criteria recommend avoiding them when possible.
- Flumazenil use is limited: While it reverses benzodiazepine effects, it can cause acute withdrawal, seizures, and arrhythmias in dependent patients. Use is largely reserved for procedural sedation reversal or pure benzodiazepine overdose without tolerance.
- CYP2C19 polymorphisms: Poor metabolizers may experience exaggerated effects; rapid metabolizers may have reduced efficacy. Genetic variation is clinically relevant but rarely tested in practice.
- Diazepam is a Schedule IV controlled substance in the US due to abuse and dependence potential.
Practice questions
1. A 68-year-old man with chronic obstructive pulmonary disease is brought to the emergency department for increasing confusion over the past two days. His daughter reports he has been taking diazepam for anxiety for several years. Physical examination shows somnolence, ataxia, and shallow respirations at 10 breaths per minute. Oxygen saturation is 88% on room air. Arterial blood gas shows respiratory acidosis. Which of the following best explains this patient's presentation?
2. A 42-year-old man with alcohol use disorder is admitted for management of alcohol withdrawal. He last drank 18 hours ago and is tremulous, diaphoretic, and anxious. Vital signs show blood pressure 160/95 mmHg and heart rate 110 beats per minute. Diazepam is initiated using a symptom-triggered protocol. Which property of diazepam makes it particularly suitable for alcohol withdrawal compared to shorter-acting benzodiazepines?
3. A 55-year-old woman with cirrhosis secondary to hepatitis C presents to the emergency department with anxiety and tremulousness. She has no history of alcohol use. The physician considers prescribing a benzodiazepine for short-term symptom relief. Which benzodiazepine would be most appropriate for this patient?
Frequently asked questions
How does diazepam work?
Diazepam enhances the effect of GABA, the brain's main inhibitory neurotransmitter, by binding to the benzodiazepine site on GABA-A receptors. This increases the frequency of chloride channel opening, leading to hyperpolarization of neurons and reduced excitability. The result is anxiolysis, sedation, muscle relaxation, and anticonvulsant activity. Unlike direct GABA agonists, diazepam requires GABA to be present, which provides a ceiling effect and relative safety in overdose.
What are the side effects of diazepam?
Common side effects include drowsiness, dizziness, confusion, muscle weakness, and ataxia. Diazepam can cause anterograde amnesia and impaired coordination, increasing fall risk, especially in the elderly. Respiratory depression is a serious risk, particularly when combined with opioids or alcohol. Long-term use leads to tolerance and physical dependence, with withdrawal symptoms including rebound anxiety, tremor, and potentially life-threatening seizures if stopped abruptly. Paradoxical reactions such as agitation or aggression can occur, especially in children and older adults.
Is diazepam a controlled substance?
Yes, diazepam is a Schedule IV controlled substance in the United States under the Controlled Substances Act. This classification reflects its accepted medical use but also its potential for abuse and dependence. Prescribers must follow specific regulations for prescribing, and patients should be monitored for signs of misuse. Physical and psychological dependence can develop with prolonged use, and abrupt discontinuation can lead to withdrawal seizures.
Diazepam vs lorazepam — what is the difference?
Both are benzodiazepines, but they differ in half-life and metabolism. Diazepam is long-acting with active metabolites lasting days, making it suitable for alcohol withdrawal but prone to accumulation in the elderly. Lorazepam is intermediate-acting with no active metabolites and undergoes direct glucuronidation, making it safer in liver disease and the elderly. For status epilepticus, lorazepam is often preferred because its anticonvulsant effect lasts longer in the brain despite diazepam's faster initial onset. Lorazepam is also more reliably absorbed intramuscularly.
Can you take diazepam during pregnancy?
Diazepam is Pregnancy Category D and should be avoided during pregnancy whenever possible. First-trimester exposure has been linked to cleft lip and palate in some studies. Use near delivery can cause floppy infant syndrome, characterized by hypotonia, hypothermia, and respiratory depression in the newborn. Chronic use during pregnancy can lead to neonatal dependence and withdrawal after birth. If diazepam is absolutely necessary, the risks and benefits must be carefully weighed, and the lowest effective dose should be used for the shortest duration.
Conditions it is used for
Related drugs
Sources and further reading
DailyMed (FDA labels)StatPearls (NCBI Bookshelf)MedlinePlusWHO ATC/DDD index: N05BA01
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.